» Articles » PMID: 33057913

Production of D-Glyceric Acid from D-Galacturonate in Escherichia Coli

Overview
Specialty Biotechnology
Date 2020 Oct 15
PMID 33057913
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A microbial production platform has been developed in Escherichia coli to synthesize D-glyceric acid from D-galacturonate. The expression of uronate dehydrogenase (udh) from Pseudomonas syringae and galactarolactone isomerase (gli) from Agrobacterium fabrum, along with the inactivation of garK, encoding for glycerate kinase, enables D-glyceric acid accumulation by utilizing the endogenous expression of galactarate dehydratase (garD), 5-keto-4-deoxy-D-glucarate aldolase (garL), and 2-hydroxy-3-oxopropionate reductase (garR). Optimization of carbon flux through the elimination of competing metabolic pathways led to the development of a ΔgarKΔhyiΔglxKΔuxaC mutant strain that produced 4.8 g/l of D-glyceric acid from D-galacturonate, with an 83% molar yield. Cultivation in a minimal medium produced similar yields and demonstrated that galactose or glycerol serve as possible carbon co-feeds for industrial production. This novel platform represents an alternative for the production of D-glyceric acid, an industrially relevant chemical, that addresses current challenges in using acetic acid bacteria for its synthesis: increasing yield, enantio-purity and biological stability.

Citing Articles

Strategies for the synthesis of the osmolyte glucosylglycerate and its precursor glycerate.

Allaert Y, Leyder A, Franceus J, Desmet T Appl Microbiol Biotechnol. 2024; 108(1):297.

PMID: 38607564 PMC: 11009771. DOI: 10.1007/s00253-024-13139-w.


A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide.

Wang X, Xiong K, Huang F, Huang J, Liu Q, Duan N Front Immunol. 2022; 13:1018567.

PMID: 36341405 PMC: 9626999. DOI: 10.3389/fimmu.2022.1018567.


Probiotic Combination CBLEB Alleviates Infection Through Immune Regulation in Immunocompromised Rats.

Lv L, Peng L, Shi D, Shao L, Jiang H, Yan R J Inflamm Res. 2022; 15:987-1004.

PMID: 35210807 PMC: 8857997. DOI: 10.2147/JIR.S348047.